EARLY ACCESS PROGRAMMES

Medicine Access with SPL Pharma​


Pharmaceutical access programs are being implemented by an increasing number of pharmaceutical companies. 
Our group have commercial operations within the UK, USA and Brazil working directly with manufacturers to enable physicians and patients access to the latest treatments on the market prior to the commercial local launch of the medication.

Our team have the experience and knowledge to ensure the correct documentation and transparency is provided to the manufacturer whilst also ensuring all pharmaceutical products supplied comply with local regulations.

EAP - Early Access Programmes
MAP - Managed Access Programmes
GAP - Global Access Programmes

To find our more about how SPL Pharma work directly with manufacturers on the above access programmes please contact us.

© 2016-2020 by Specialty Pharma of London LTD
Company Reg No: 10167709
WDA Licence: WDA(H)46315

UK Tel: +44 (0) 207 182 4992  
Brasil - Cel / Whatsapp: +55-11-96059-4029

spl@splpharma.co.uk

  • LinkedIn - Black Circle
  • Black Facebook Icon
  • Black Twitter Icon